about
Therapeutic complement inhibition – from experimental to clinical medicineAtrial fibrillation: inflammation in disguise?Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases-C3 or C5 emerge together with CD14 as promising targetsThe complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosisThe Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomesToward an injectable continuous osmotic glucose sensorExcessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza.Gene expression profiling of Gram-negative bacteria-induced inflammation in human whole blood: The role of complement and CD14-mediated innate immune responseInflammatory Response After Laparoscopic Versus Open Resection of Colorectal Liver Metastases: Data From the Oslo-CoMet TrialComplement analysis in clinic and research.Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis.Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission.Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndrome.Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies.Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality.Xenotransplantation: how to overcome the complement obstacle?CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs.Iron oxide nanoparticles induce cytokine secretion in a complement-dependent manner in a human whole blood modelAssessments of skin and tongue microcirculation reveals major changes in porcine sepsis.Ficolins do not alter host immune responses to lipopolysaccharide-induced inflammation in vivo.Pig endogenous retrovirus--a threat to clinical xenotransplantation?Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis.Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosisC1-inhibitor: an anti-inflammatory reagent with therapeutic potential.Deposits of terminal complement complex (TCC) in muscularis mucosae and submucosal vessels in ulcerative colitis and Crohn's disease of the colon.Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.Low levels of vitronectin and clusterin in acute meningococcal disease are closely associated with formation of the terminal-complement complex and the vitronectin-thrombin-antithrombin complex.High frequency and intensity of drinking may attenuate increased inflammatory cytokine levels of major depression in alcohol-use disorders.Complement analysis in the 21st century.Association of ficolin-3 with severity and outcome of chronic heart failure.Cytokine network in adults with falciparum Malaria and HIV-1: increased IL-8 and IP-10 levels are associated with disease severity.Albumin lavage does not improve the outcome of meconium aspiration syndrome.Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis.Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosisComplement C3 and C5 deficiency affects fracture healingArtificial surface-induced inflammation relies on complement factor 5: proof from a deficient person.Development of β-amino alcohol derivatives that inhibit Toll-like receptor 4 mediated inflammatory response as potential antiseptics.Measurement of complement activation.Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human bloodPerspectives on complement in xenotransplantation.
P50
Q26781190-26A60B07-2CFE-4DE4-B52B-535E3AFD76E6Q27693290-0F0F1D67-0742-473B-8FAC-0577027A3AC2Q28077955-9F925652-041E-46C3-8265-C42789B2D28DQ28083548-AD2997C9-0208-40DD-BB16-3C29196C0B38Q28295227-BFF01403-320F-4033-A754-74465A2D6713Q30391894-85B36C18-E493-4BEE-8FE4-D3D47C31AE66Q30405122-125F2C0E-9230-42B6-B676-E598E92FC688Q30488438-08876277-D1B4-463C-9246-E7B5B039ACDBQ31010163-546A0654-D222-4B53-AA01-25B1F3F4BA2AQ33372177-5350FD64-B485-4CD8-9102-1BE3C719CED1Q33389544-4F052FD4-10B6-4F5F-B527-7B2841A12708Q33416830-4F2CD54B-381B-4DA3-A691-170B7DAE7453Q33423884-0DE6B6B0-AE4F-426C-A702-FD775BBA8983Q33613839-50FADF20-0395-4D49-8DCB-856D24FA2F58Q33618032-D0E44F75-40B4-40B1-B018-0E9E9862FC62Q33686083-2F41C99F-904B-4523-BCDC-4420B26FA8D7Q33694581-43379F4C-3A1F-447D-AA4C-766C8AFF05ABQ33739773-4754981E-8135-45EC-A65C-3ACAEC9BABE6Q33750678-B478CFCE-028A-432B-BE44-BA507329033FQ33819173-6E1BA3CD-2483-4C4F-8C24-191115C027B7Q33937506-704E380B-BDF6-40C4-90BA-F1486F64F51EQ34025504-2AD74623-9BAD-4B80-814A-03D381EC0794Q34316549-F157B39A-96D2-499C-A27C-7A73AB14474EQ34388554-0DF550DC-2F80-4ABE-A2C4-DCF1E2F9778AQ34392163-8D92DBC8-F054-455A-BC51-3EC8E01B8CB4Q34395719-A7F43C45-741C-4496-8F30-A0B4546F0519Q34544169-338B981E-3BD5-4950-BAE5-92CD82E0C941Q34637905-FF6C9735-850D-4260-9C04-58E7C4F032C2Q34674625-2D6F8AFD-EA97-425B-9DC0-483EC482C3A9Q34676160-BB867E15-4200-4939-873C-333EC3F64CBAQ34682109-F6424887-24B4-4E33-A3C7-44F7078ACEABQ34881427-D62CFC5B-F9E4-4454-923C-64C9D007615BQ34911214-D2C5F3AC-4C6E-4C43-A70A-BD27CBD85264Q34983608-382C21CE-5E31-4783-A350-30F840D6B33CQ35049546-B9FFE78C-5C20-4B7E-8863-9FF2D394E9F6Q35069163-585BAE31-2CB9-4943-99B8-E90062BA522BQ35091378-B004FCB9-BE16-44E7-A8BC-3B0A9069A40FQ35137245-754EBE6F-45E2-4065-8E05-41638D50716DQ35186384-9C975B3B-ACA1-4C3C-9619-BAD0320E7779Q35197936-FEFBC2AD-9D73-4E1E-A2EA-085FA7350AE2
P50
description
Noors onderzoeker
@nl
investigador
@es
norsk forsker
@nb
researcher
@en
name
Tom Eirik Mollnes
@da
Tom Eirik Mollnes
@de
Tom Eirik Mollnes
@en
Tom Eirik Mollnes
@es
Tom Eirik Mollnes
@nb
Tom Eirik Mollnes
@nl
Tom Eirik Mollnes
@sl
type
label
Tom Eirik Mollnes
@da
Tom Eirik Mollnes
@de
Tom Eirik Mollnes
@en
Tom Eirik Mollnes
@es
Tom Eirik Mollnes
@nb
Tom Eirik Mollnes
@nl
Tom Eirik Mollnes
@sl
altLabel
Tom E Mollnes
@en
Tom E. Mollnes
@nb
Tom Mollnes
@nb
prefLabel
Tom Eirik Mollnes
@da
Tom Eirik Mollnes
@de
Tom Eirik Mollnes
@en
Tom Eirik Mollnes
@es
Tom Eirik Mollnes
@nb
Tom Eirik Mollnes
@nl
Tom Eirik Mollnes
@sl
P106
P2038
Tom_Mollnes
P21
P214
5341149108590068780000
P2287
P27
P31
P496
0000-0002-5785-802X
P569
1956-01-01T00:00:00Z
P735
P7859
viaf-5341149108590068780000